Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sajad Darou Shargh is a prominent Iranian pharmaceutical manufacturer based in Mashhad, specializing in the production of a wide range of generic medications. As a key subsidiary of the Razavi Pharmaceutical Group, the company operates state-of-the-art facilities that adhere to international Good Manufacturing Practice (GMP) standards. Its core expertise lies in the formulation of topical products, including ointments, creams, and gels, as well as oral liquid dosage forms such as syrups and drops. The company plays a vital role in the regional healthcare supply chain, providing essential treatments across therapeutic areas including dermatology, respiratory health, and pediatrics. Sajad Darou Shargh is part of the broader economic network of Astan Quds Razavi, contributing to pharmaceutical self-sufficiency in the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sajad darou shargh.